ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
Gespeichert in:
| Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 2010-12, Vol.122 (24), p.2619-2633 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2633 |
|---|---|
| container_issue | 24 |
| container_start_page | 2619 |
| container_title | Circulation (New York, N.Y.) |
| container_volume | 122 |
| creator | Abraham, Neena S Hlatky, Mark A Antman, Elliott M Bhatt, Deepak L Bjorkman, David J Clark, Craig B Furberg, Curt D Johnson, David A Kahi, Charles J Laine, Loren Mahaffey, Kenneth W Quigley, Eamonn M Scheiman, James Sperling, Laurence S Tomaselli, Gordon F |
| description | |
| doi_str_mv | 10.1161/CIR.0b013e318202f701 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_818402096</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>818402096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c255t-3a94bb7be98b70b392b721139f6e14805bdf3f612837b7b2cc1e8cdc911486b63</originalsourceid><addsrcrecordid>eNp1kltv1DAQhQMqokvhHyDktz6l60uuvEVpt12pKhKU58h2JlvTxA6-SOy_x9ltK1SJJ8uec2Y-jU-SfCb4gpCCrNvt9wssMGHASEUxHUpM3iYrktMszXJWnyQrjHGdlozS0-SDc7_itWBl_j45pQQXGJfl6s3QtO1m3bTX6-amQRQTjK7-zGA9ao12oF1w6NLIMIH2yGjkHwBJo6WZlOfxKThAZkCzNT5W5zDNSOkHJZQ31iGu--hQoM28t6pXGtxXxNEQGzroUZh77g_-pe0rElwhOJLIF5L-HxILfZBK7w7eHXfeGqU9OK80H5FV7tEtnSOkmsc4ZgS_SC2f9weuux_N9nLhX4gszCZOeiaZwCrJddzBOMLuQNhy2yszmt0ebUzQEVxFiHvuHuPdSliQ_rs59zF5N_DRwaen8yz5ubm6b2_S22_X27a5TSXNc58yXmdClALqSpRYsJqKkhLC6qEAklU4F_3AhoLQipVRRqUkUMle1iRWC1Gws-T82Dd-yO8Ql9FNykkYR67BBNdVpMowxfWizI5KaY1zFoZutmridt8R3C0B62LAutcBi7YvTwOCmKB_MT0niv0F_njRtg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>818402096</pqid></control><display><type>article</type><title>ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><source>American Heart Association</source><source>Journals@Ovid Complete</source><creator>Abraham, Neena S ; Hlatky, Mark A ; Antman, Elliott M ; Bhatt, Deepak L ; Bjorkman, David J ; Clark, Craig B ; Furberg, Curt D ; Johnson, David A ; Kahi, Charles J ; Laine, Loren ; Mahaffey, Kenneth W ; Quigley, Eamonn M ; Scheiman, James ; Sperling, Laurence S ; Tomaselli, Gordon F</creator><creatorcontrib>Abraham, Neena S ; Hlatky, Mark A ; Antman, Elliott M ; Bhatt, Deepak L ; Bjorkman, David J ; Clark, Craig B ; Furberg, Curt D ; Johnson, David A ; Kahi, Charles J ; Laine, Loren ; Mahaffey, Kenneth W ; Quigley, Eamonn M ; Scheiman, James ; Sperling, Laurence S ; Tomaselli, Gordon F ; ACCF/ACG/AHA ; Writing Committee Members</creatorcontrib><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIR.0b013e318202f701</identifier><identifier>PMID: 21060077</identifier><language>eng</language><publisher>United States</publisher><subject><![CDATA[Anti-Inflammatory Agents, Non-Steroidal - administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal - adverse effects ; Anti-Inflammatory Agents, Non-Steroidal - metabolism ; Aryl Hydrocarbon Hydroxylases - metabolism ; Aspirin - administration & dosage ; Aspirin - adverse effects ; Aspirin - metabolism ; Cardiovascular Diseases - drug therapy ; Cytochrome P-450 CYP2C19 ; Drug Interactions ; Drug Therapy, Combination ; Gastrointestinal Hemorrhage - chemically induced ; Gastrointestinal Hemorrhage - prevention & control ; Histamine H2 Antagonists - administration & dosage ; Histamine H2 Antagonists - adverse effects ; Histamine H2 Antagonists - metabolism ; Humans ; Piperazines - administration & dosage ; Piperazines - adverse effects ; Piperazines - metabolism ; Platelet Aggregation Inhibitors - administration & dosage ; Platelet Aggregation Inhibitors - adverse effects ; Platelet Aggregation Inhibitors - metabolism ; Prasugrel Hydrochloride ; Proton Pump Inhibitors - administration & dosage ; Proton Pump Inhibitors - adverse effects ; Proton Pump Inhibitors - metabolism ; Purinergic P2Y Receptor Antagonists - administration & dosage ; Purinergic P2Y Receptor Antagonists - adverse effects ; Purinergic P2Y Receptor Antagonists - metabolism ; Risk Factors ; Thienopyridines - administration & dosage ; Thienopyridines - adverse effects ; Thienopyridines - metabolism ; Thiophenes - administration & dosage ; Thiophenes - adverse effects ; Thiophenes - metabolism ; Ticlopidine - administration & dosage ; Ticlopidine - adverse effects ; Ticlopidine - analogs & derivatives ; Ticlopidine - metabolism]]></subject><ispartof>Circulation (New York, N.Y.), 2010-12, Vol.122 (24), p.2619-2633</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c255t-3a94bb7be98b70b392b721139f6e14805bdf3f612837b7b2cc1e8cdc911486b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3687,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21060077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abraham, Neena S</creatorcontrib><creatorcontrib>Hlatky, Mark A</creatorcontrib><creatorcontrib>Antman, Elliott M</creatorcontrib><creatorcontrib>Bhatt, Deepak L</creatorcontrib><creatorcontrib>Bjorkman, David J</creatorcontrib><creatorcontrib>Clark, Craig B</creatorcontrib><creatorcontrib>Furberg, Curt D</creatorcontrib><creatorcontrib>Johnson, David A</creatorcontrib><creatorcontrib>Kahi, Charles J</creatorcontrib><creatorcontrib>Laine, Loren</creatorcontrib><creatorcontrib>Mahaffey, Kenneth W</creatorcontrib><creatorcontrib>Quigley, Eamonn M</creatorcontrib><creatorcontrib>Scheiman, James</creatorcontrib><creatorcontrib>Sperling, Laurence S</creatorcontrib><creatorcontrib>Tomaselli, Gordon F</creatorcontrib><creatorcontrib>ACCF/ACG/AHA</creatorcontrib><creatorcontrib>Writing Committee Members</creatorcontrib><title>ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><subject>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - metabolism</subject><subject>Aryl Hydrocarbon Hydroxylases - metabolism</subject><subject>Aspirin - administration & dosage</subject><subject>Aspirin - adverse effects</subject><subject>Aspirin - metabolism</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cytochrome P-450 CYP2C19</subject><subject>Drug Interactions</subject><subject>Drug Therapy, Combination</subject><subject>Gastrointestinal Hemorrhage - chemically induced</subject><subject>Gastrointestinal Hemorrhage - prevention & control</subject><subject>Histamine H2 Antagonists - administration & dosage</subject><subject>Histamine H2 Antagonists - adverse effects</subject><subject>Histamine H2 Antagonists - metabolism</subject><subject>Humans</subject><subject>Piperazines - administration & dosage</subject><subject>Piperazines - adverse effects</subject><subject>Piperazines - metabolism</subject><subject>Platelet Aggregation Inhibitors - administration & dosage</subject><subject>Platelet Aggregation Inhibitors - adverse effects</subject><subject>Platelet Aggregation Inhibitors - metabolism</subject><subject>Prasugrel Hydrochloride</subject><subject>Proton Pump Inhibitors - administration & dosage</subject><subject>Proton Pump Inhibitors - adverse effects</subject><subject>Proton Pump Inhibitors - metabolism</subject><subject>Purinergic P2Y Receptor Antagonists - administration & dosage</subject><subject>Purinergic P2Y Receptor Antagonists - adverse effects</subject><subject>Purinergic P2Y Receptor Antagonists - metabolism</subject><subject>Risk Factors</subject><subject>Thienopyridines - administration & dosage</subject><subject>Thienopyridines - adverse effects</subject><subject>Thienopyridines - metabolism</subject><subject>Thiophenes - administration & dosage</subject><subject>Thiophenes - adverse effects</subject><subject>Thiophenes - metabolism</subject><subject>Ticlopidine - administration & dosage</subject><subject>Ticlopidine - adverse effects</subject><subject>Ticlopidine - analogs & derivatives</subject><subject>Ticlopidine - metabolism</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kltv1DAQhQMqokvhHyDktz6l60uuvEVpt12pKhKU58h2JlvTxA6-SOy_x9ltK1SJJ8uec2Y-jU-SfCb4gpCCrNvt9wssMGHASEUxHUpM3iYrktMszXJWnyQrjHGdlozS0-SDc7_itWBl_j45pQQXGJfl6s3QtO1m3bTX6-amQRQTjK7-zGA9ao12oF1w6NLIMIH2yGjkHwBJo6WZlOfxKThAZkCzNT5W5zDNSOkHJZQ31iGu--hQoM28t6pXGtxXxNEQGzroUZh77g_-pe0rElwhOJLIF5L-HxILfZBK7w7eHXfeGqU9OK80H5FV7tEtnSOkmsc4ZgS_SC2f9weuux_N9nLhX4gszCZOeiaZwCrJddzBOMLuQNhy2yszmt0ebUzQEVxFiHvuHuPdSliQ_rs59zF5N_DRwaen8yz5ubm6b2_S22_X27a5TSXNc58yXmdClALqSpRYsJqKkhLC6qEAklU4F_3AhoLQipVRRqUkUMle1iRWC1Gws-T82Dd-yO8Ql9FNykkYR67BBNdVpMowxfWizI5KaY1zFoZutmridt8R3C0B62LAutcBi7YvTwOCmKB_MT0niv0F_njRtg</recordid><startdate>20101214</startdate><enddate>20101214</enddate><creator>Abraham, Neena S</creator><creator>Hlatky, Mark A</creator><creator>Antman, Elliott M</creator><creator>Bhatt, Deepak L</creator><creator>Bjorkman, David J</creator><creator>Clark, Craig B</creator><creator>Furberg, Curt D</creator><creator>Johnson, David A</creator><creator>Kahi, Charles J</creator><creator>Laine, Loren</creator><creator>Mahaffey, Kenneth W</creator><creator>Quigley, Eamonn M</creator><creator>Scheiman, James</creator><creator>Sperling, Laurence S</creator><creator>Tomaselli, Gordon F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101214</creationdate><title>ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents</title><author>Abraham, Neena S ; Hlatky, Mark A ; Antman, Elliott M ; Bhatt, Deepak L ; Bjorkman, David J ; Clark, Craig B ; Furberg, Curt D ; Johnson, David A ; Kahi, Charles J ; Laine, Loren ; Mahaffey, Kenneth W ; Quigley, Eamonn M ; Scheiman, James ; Sperling, Laurence S ; Tomaselli, Gordon F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c255t-3a94bb7be98b70b392b721139f6e14805bdf3f612837b7b2cc1e8cdc911486b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - metabolism</topic><topic>Aryl Hydrocarbon Hydroxylases - metabolism</topic><topic>Aspirin - administration & dosage</topic><topic>Aspirin - adverse effects</topic><topic>Aspirin - metabolism</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cytochrome P-450 CYP2C19</topic><topic>Drug Interactions</topic><topic>Drug Therapy, Combination</topic><topic>Gastrointestinal Hemorrhage - chemically induced</topic><topic>Gastrointestinal Hemorrhage - prevention & control</topic><topic>Histamine H2 Antagonists - administration & dosage</topic><topic>Histamine H2 Antagonists - adverse effects</topic><topic>Histamine H2 Antagonists - metabolism</topic><topic>Humans</topic><topic>Piperazines - administration & dosage</topic><topic>Piperazines - adverse effects</topic><topic>Piperazines - metabolism</topic><topic>Platelet Aggregation Inhibitors - administration & dosage</topic><topic>Platelet Aggregation Inhibitors - adverse effects</topic><topic>Platelet Aggregation Inhibitors - metabolism</topic><topic>Prasugrel Hydrochloride</topic><topic>Proton Pump Inhibitors - administration & dosage</topic><topic>Proton Pump Inhibitors - adverse effects</topic><topic>Proton Pump Inhibitors - metabolism</topic><topic>Purinergic P2Y Receptor Antagonists - administration & dosage</topic><topic>Purinergic P2Y Receptor Antagonists - adverse effects</topic><topic>Purinergic P2Y Receptor Antagonists - metabolism</topic><topic>Risk Factors</topic><topic>Thienopyridines - administration & dosage</topic><topic>Thienopyridines - adverse effects</topic><topic>Thienopyridines - metabolism</topic><topic>Thiophenes - administration & dosage</topic><topic>Thiophenes - adverse effects</topic><topic>Thiophenes - metabolism</topic><topic>Ticlopidine - administration & dosage</topic><topic>Ticlopidine - adverse effects</topic><topic>Ticlopidine - analogs & derivatives</topic><topic>Ticlopidine - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abraham, Neena S</creatorcontrib><creatorcontrib>Hlatky, Mark A</creatorcontrib><creatorcontrib>Antman, Elliott M</creatorcontrib><creatorcontrib>Bhatt, Deepak L</creatorcontrib><creatorcontrib>Bjorkman, David J</creatorcontrib><creatorcontrib>Clark, Craig B</creatorcontrib><creatorcontrib>Furberg, Curt D</creatorcontrib><creatorcontrib>Johnson, David A</creatorcontrib><creatorcontrib>Kahi, Charles J</creatorcontrib><creatorcontrib>Laine, Loren</creatorcontrib><creatorcontrib>Mahaffey, Kenneth W</creatorcontrib><creatorcontrib>Quigley, Eamonn M</creatorcontrib><creatorcontrib>Scheiman, James</creatorcontrib><creatorcontrib>Sperling, Laurence S</creatorcontrib><creatorcontrib>Tomaselli, Gordon F</creatorcontrib><creatorcontrib>ACCF/ACG/AHA</creatorcontrib><creatorcontrib>Writing Committee Members</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abraham, Neena S</au><au>Hlatky, Mark A</au><au>Antman, Elliott M</au><au>Bhatt, Deepak L</au><au>Bjorkman, David J</au><au>Clark, Craig B</au><au>Furberg, Curt D</au><au>Johnson, David A</au><au>Kahi, Charles J</au><au>Laine, Loren</au><au>Mahaffey, Kenneth W</au><au>Quigley, Eamonn M</au><au>Scheiman, James</au><au>Sperling, Laurence S</au><au>Tomaselli, Gordon F</au><aucorp>ACCF/ACG/AHA</aucorp><aucorp>Writing Committee Members</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2010-12-14</date><risdate>2010</risdate><volume>122</volume><issue>24</issue><spage>2619</spage><epage>2633</epage><pages>2619-2633</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><cop>United States</cop><pmid>21060077</pmid><doi>10.1161/CIR.0b013e318202f701</doi><tpages>15</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-7322 |
| ispartof | Circulation (New York, N.Y.), 2010-12, Vol.122 (24), p.2619-2633 |
| issn | 0009-7322 1524-4539 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_818402096 |
| source | MEDLINE; EZB Electronic Journals Library; American Heart Association; Journals@Ovid Complete |
| subjects | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - adverse effects Anti-Inflammatory Agents, Non-Steroidal - metabolism Aryl Hydrocarbon Hydroxylases - metabolism Aspirin - administration & dosage Aspirin - adverse effects Aspirin - metabolism Cardiovascular Diseases - drug therapy Cytochrome P-450 CYP2C19 Drug Interactions Drug Therapy, Combination Gastrointestinal Hemorrhage - chemically induced Gastrointestinal Hemorrhage - prevention & control Histamine H2 Antagonists - administration & dosage Histamine H2 Antagonists - adverse effects Histamine H2 Antagonists - metabolism Humans Piperazines - administration & dosage Piperazines - adverse effects Piperazines - metabolism Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - metabolism Prasugrel Hydrochloride Proton Pump Inhibitors - administration & dosage Proton Pump Inhibitors - adverse effects Proton Pump Inhibitors - metabolism Purinergic P2Y Receptor Antagonists - administration & dosage Purinergic P2Y Receptor Antagonists - adverse effects Purinergic P2Y Receptor Antagonists - metabolism Risk Factors Thienopyridines - administration & dosage Thienopyridines - adverse effects Thienopyridines - metabolism Thiophenes - administration & dosage Thiophenes - adverse effects Thiophenes - metabolism Ticlopidine - administration & dosage Ticlopidine - adverse effects Ticlopidine - analogs & derivatives Ticlopidine - metabolism |
| title | ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A33%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ACCF/ACG/AHA%202010%20Expert%20Consensus%20Document%20on%20the%20concomitant%20use%20of%20proton%20pump%20inhibitors%20and%20thienopyridines:%20a%20focused%20update%20of%20the%20ACCF/ACG/AHA%202008%20expert%20consensus%20document%20on%20reducing%20the%20gastrointestinal%20risks%20of%20antiplatelet%20therapy%20and%20NSAID%20use:%20a%20report%20of%20the%20American%20College%20of%20Cardiology%20Foundation%20Task%20Force%20on%20Expert%20Consensus%20Documents&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Abraham,%20Neena%20S&rft.aucorp=ACCF/ACG/AHA&rft.date=2010-12-14&rft.volume=122&rft.issue=24&rft.spage=2619&rft.epage=2633&rft.pages=2619-2633&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIR.0b013e318202f701&rft_dat=%3Cproquest_cross%3E818402096%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=818402096&rft_id=info:pmid/21060077&rfr_iscdi=true |